Max Goes to the World Cancer Congress
The Union for International Cancer Control (UICC) has been hosting the World Cancer Congress each year since 1933. This year it was held in Malaysia – the first time in South East Asia.
Max Tracks: Africa – Tanzania
Get a never before seen look at the chronic myeloid leukemia (CML) program in Tanzania! Over 20 years ago, we partnered with local healthcare professionals to provide treatment access for people living with cancer – at no cost to them, for as long as they need
it.
Africa Region Head Cathy Scheepers takes you to clinics in Moshi and Dar es Salaam, talking with patients, advocates, and physicians about their progress and how we can reach more people living with CML.
Stay tuned for more behind-the-scenes videos! Cathy and the Max team will be visiting several countries this year, including Lesotho, Kenya, Malawi, Sierra Leone, and Ethiopia.
Join our email list for updates and follow along on social media to join the conversation.
The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.
Related Articles
The Brave Fisherwoman: In Remembrance of Hira Goma
In all these years, through all of the struggle and emotional upheaval of her diagnosis, Hira remained her active and busy self. She never missed her daily routine of the wharf and the bazaar, nor did she let her work and routine come in the way of her managing her CML.
7 Questions for Dr. Jayasree Iyer of Access to Medicine Foundation
Dr. Jayasree Iyer, Executive Director of the Access to Medicine Foundation (ATMF), sits down with The Max Foundation and answers seven questions about the Access to Medicine Index, emerging trends in treatment access, and the role of collaborative access initiatives in treating chronic diseases.